Quick Answer
Core Laboratories Inc. /DE/ reported Stockholders Equity of $265.99 million for fiscal year 2025.
Core Laboratories Inc. /DE/ Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $265.99M | +7.9% |
| 2024 | $246.57M | +9.7% |
| 2023 | $224.81M | +22.0% |
| 2022 | $184.26M | +14.4% |
| 2021 | $161.00M | +113.0% |
| 2020 | $75.57M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $271.35M | +8.2% | +3.9% |
| June 30, 2025 | $261.28M | +8.7% | +3.1% |
| March 31, 2025 | $253.39M | +9.1% | +0.6% |
| December 31, 2024 | $251.99M | +12.1% | +0.5% |
| September 30, 2024 | $250.74M | +11.6% | +4.4% |
| June 30, 2024 | $240.27M | +11.9% | +3.5% |
| March 31, 2024 | $232.16M | +16.0% | +3.3% |
| December 31, 2023 | $224.81M | +22.0% | +0.1% |
- Core Laboratories Inc. /DE/ showed an increase of +7.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Core Laboratories Inc. /DE/’s stockholders equity has grown by 252.0% (from $75.57 million to $265.99 million).
- The most recent figure is from Core Laboratories Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: